Stock comparison
DEXCOM INC is 7.1x more valuable than HAEMONETICS CORP by market capitalization ($32.81 B vs $4.64 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
DXCM is larger
DEXCOM INC is 7.1x more valuable than HAEMONETICS CORP by market capitalization ($32.81 B vs $4.64 B).
Market value leader
DXCM
DEXCOM INC is 7.1x more valuable than HAEMONETICS CORP by market capitalization ($32.81 B vs $4.64 B).
Revenue leader
DXCM
HAE: $1.33B vs DXCM: $4.66B.
Profit leader
DXCM
HAE: $97.31M vs DXCM: $836.30M.
Margin leader
DXCM
HAE: 7.3% vs DXCM: 17.9% net margin.
| Metric | HAE | DXCM |
|---|---|---|
| Market cap | $4.64 B | $32.81 B |
| US-listed rank | #1475 | #443 |
| Revenue (latest FY) | $1.33B | $4.66B |
| Net income (latest FY) | $97.31M | $836.30M |
| Net margin | 7.3% | 17.9% |
| P/E (trailing FY) | 47.7x | 39.2x |
| SEC filings | 1,875 | 2,566 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
DEXCOM INC is 7.1x more valuable than HAEMONETICS CORP by market capitalization ($32.81 B vs $4.64 B).
In their latest fiscal years, HAEMONETICS CORP reported $1.33B in revenue while DEXCOM INC reported $4.66B.
Full pages: HAEMONETICS CORP and DEXCOM INC, or browse the full rankings.